Clinical Trial Update: Directed Immuno Nutrition by L-arginine for Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating directed immunonutrition with L-arginine in critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Critically Ill | Phase 4 | Status: COMPLETED